Group Video vs Self-Directed Methods for Prediabetes
(RAD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine which method better helps adults in rural areas manage prediabetes: group video sessions (Zoom Group Video) or self-directed programs (Self Directed). The researchers seek to identify the most effective approach and understand the challenges or supports that influence the success of these programs. Suitable participants typically have a body mass index (BMI) over 25 and have recently been diagnosed with prediabetes, possibly through a blood test or previous pregnancy-related diabetes. Participants must be able to travel for meetings and speak English.
As an unphased trial, this study offers participants the chance to contribute to valuable research that could enhance prediabetes management in rural communities.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, if you are taking FDA-approved weight loss medications, you would not be eligible to participate.
What prior data suggests that these delivery methods are safe for prediabetic adults?
Research has shown that both the Zoom Group Video and Self-Directed methods for the National Diabetes Prevention Program (NDPP) are safe for participants.
For the Zoom Group Video method, studies indicate it is effective and easy to use. Adults who joined the program through Zoom found it simple to follow. These studies reported no major side effects, suggesting it is well-tolerated.
The Self-Directed NDPP has undergone thorough research and helps participants reduce their risk of developing type 2 diabetes by making lifestyle changes. Like the Zoom method, this approach is also safe, with no major side effects reported.
Both methods focus on lifestyle changes and are designed to be safe and supportive for people aiming to prevent diabetes.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores new ways of empowering people with prediabetes through lifestyle changes. Unlike traditional methods that often require in-person classes or one-on-one sessions, this trial tests the effectiveness of a Group Video Diabetes Prevention Program using Zoom, offering a flexible and accessible approach. Additionally, the self-directed program allows participants to manage their health on their own schedule, potentially increasing adherence and engagement. By comparing these methods, researchers hope to discover more effective and convenient strategies for preventing diabetes, which could make a significant difference in managing the condition globally.
What evidence suggests that this trial's treatments could be effective for prediabetes?
This trial will compare two methods of delivering the National Diabetes Prevention Program (NDPP): group video sessions and self-directed methods. Research has shown that the NDPP effectively lowers the risk of developing type 2 diabetes, regardless of delivery method. Participants in the group video arm, using platforms like Zoom, demonstrated positive changes, such as weight loss and improved blood sugar levels. Meanwhile, the self-directed arm allows participants to follow the program independently. Studies suggest that digital methods, like Zoom, are particularly beneficial for adults in rural areas at risk for type 2 diabetes. Overall, adhering to the program leads to positive outcomes, whether through video calls or self-directed efforts.678910
Who Is on the Research Team?
Anna M Gorczyca, PhD
Principal Investigator
University of Kansas Medical Center
Are You a Good Fit for This Trial?
This trial is for adults in rural areas with prediabetes, which means they have blood test results showing slightly elevated sugar levels or a previous diagnosis of gestational diabetes. Participants must be over 18, have a BMI ≥25 (or ≥23 if Asian), and speak English. They should be able to attend group video meetings and travel to the study site for orientation and testing.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either the group video or self-directed Diabetes Prevention Program for 12 months
Follow-up
Participants are monitored for weight, physical activity, and HbA1c changes
What Are the Treatments Tested in This Trial?
Interventions
- Self Directed
- Zoom Group Video
Self Directed is already approved in United States for the following indications:
- Prediabetes
- Type 2 Diabetes Prevention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Kansas Medical Center
Lead Sponsor
Kansas State University
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator